Traynor Capital Management’s Teladoc Health TDOC Stock Holding History

Traynor Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,803	Closed	-$38.9K	–	303
2023 Q4	$38.9K	Buy	+1,803	New	+$33.3K	﹤0.01%	224
2022 Q2	–	Sell	-3,086	Closed	-$222K	–	211
2022 Q1	$222K	Buy	+3,086	New	+$222K	0.03%	165
2021 Q4	–	Sell	-3,031	Closed	-$384K	–	234
2021 Q3	$384K	Sell	3,031 -971	-24%	-$141K	0.05%	134
2021 Q2	$657K	Buy	4,002 +1,885	+89%	+$305K	0.09%	101
2021 Q1	$384K	Sell	2,117 -529	-20%	-$123K	0.06%	118
2020 Q4	$529K	Sell	2,646 -1,600	-38%	-$325K	0.09%	96
2020 Q3	$918K	Buy	4,246 +655	+18%	+$139K	0.21%	63
2020 Q2	$685K	Buy	3,591 +1,162	+48%	+$204K	0.17%	73
2020 Q1	$376K	Buy	+2,429	New	+$283K	0.13%	84

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Traynor Capital Management's TDOC Position: Q1 2024 in Review

Traynor Capital Management sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 1,803 shares — an estimated $38.9K sold.

Traynor Capital Management first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $918K in Q3 2020. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

Traynor Capital Management reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
Traynor Capital Management sold 1,803 Teladoc Health shares in Q1 2024, an estimated $38.9K.
Traynor Capital Management first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
Traynor Capital Management's Teladoc Health position peaked at $918K in Q3 2020.
426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Traynor Capital Management's 13F filing for Q1 2024, filed 12 Apr 2024.